Kurma Partners's book
31 companies · priced by our data| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| Merlyn Mind | — | $668.0M | — | — | |
| DNA Script | Biotechnology | $659.7M | — | — | |
| Alveus Therapeutics | — | $275.2M | — | — | |
| Adcytherix | Drug Discovery | $213.3M | — | — | |
| Nuclidium | — | $163.2M | — | — | |
| Germitec | — | $137.0M | — | — | |
| Step Pharma | — | $118.0M | — | — | |
| Xeltis | — | $107.5M | — | — | |
| Sunrise (Diagnostic Equipment) | — | $101.0M | — | — | |
| Shorla Oncology | — | $90.3M | — | — | |
| + 21 more companies · a free account shows the top 25 | |||||
Free account
See the whole book
- ·The book's top 25 — of 31 recorded positions
- ·Watchlist + alerts for Kurma Partners's activity
Create free account
No card required